The situation of pharmaceutical industry is grim, how to survive for small and medium-sized pharmaceutical enterprises

[pharmaceutical network industry trends] it was predicted that Chinese pharmaceutical enterprises will usher in the era of "big differentiation" In fact, under the influence of policies such as "4 + 7" volume purchase, drug consistency evaluation, medical insurance and fee control, the ecosystem of China's pharmaceutical industry is gradually reconstructing, and the days when pharmaceutical enterprises "lie down to make money" have gone forever In this regard, there are industry analysis, there will be a number of small and medium-sized pharmaceutical manufacturers or active or passive exit from the market The situation of the pharmaceutical industry is grim How can small and medium-sized pharmaceutical enterprises survive? So, under this prediction, how can large, medium and large-sized pharmaceutical enterprises change to avoid being eliminated? Pharmaceutical enterprises need core products with characteristics At present, with the implementation of the volume purchase policy, the concentration of the pharmaceutical industry will further improve, and the market competition will become increasingly fierce It has become a consensus that pharmaceutical companies with weak strength and innovation will be eliminated by the market Therefore, whether a pharmaceutical enterprise has a unique core product is crucial to its development The so-called characteristic mainly refers to the fact that no one has it and no one has it The market capacity of the product does not have to be large, but there should be selling points, and the pain points of the product solution should be accurate and deep Therefore, when pharmaceutical enterprises first choose to build distinctive core products, they should pay attention to not too many product approvals, otherwise, in the process of building and promoting products, it is easy to be intercepted by other enterprises' products at the terminal, which will hit the marketing morale of enterprises, and then lose stronger competitiveness In addition, we should also choose drugs with special efficacy differences Good drugs have unique curative effects First, the marketing team is more likely to accept them Second, the end users are more likely to accept them in the process of promotion It is also convenient to recommend them to patients Undoubtedly, choosing such products will be much easier in the later marketing process In the process of looking for core drugs, pharmaceutical companies can organize marketing teams or consulting teams to combine their own conditions, through market research and analysis, find out suitable products from a series of products as featured core products This step seems simple, but it is crucial Pharmaceutical enterprises need to have specialized means Pharmaceutical enterprises need to be specialized Differentiated characteristic products need to be realized by professional means Specialized technology level, specialized service ability, specialized marketing methods, etc are all means to realize product value From the perspective of production, specialization means that pharmaceutical enterprises should improve labor productivity, reduce labor costs, and improve product capacity and production efficiency by accelerating equipment upgrading In this link, pharmaceutical enterprises cannot do without the cooperation and support of pharmaceutical equipment It is understood that most pharmaceutical machinery enterprises are improving the level of automation and intelligence of equipment through continuous innovation and upgrading to provide strong support for improving the production efficiency of pharmaceutical enterprises From the perspective of sales, pharmaceutical companies should also actively seek change The industry believes that the essence of all current policies and trends is to let drugs with poor efficacy or safety out of the market, make good varieties and academic promotion become the core of market competition in the future, and force enterprises to return to the right path of innovation and academic Therefore, in the future, pharmaceutical companies need to cultivate a group of training and sales teams with strength to promote products, and can timely change the marketing mode according to the actual situation Conclusion: in general, the current situation of the pharmaceutical industry is indeed more and more severe, which will have a great impact on the development of small and medium-sized pharmaceutical enterprises! In the future, small and medium-sized enterprises can only go further and further in the current environment if they constantly obtain reasonable profits and update their core products